RIGLRigel Pharmaceuticals, Inc.
$48.76+65% 1Y
$48.76
$25.4452 weeks$50.96
Is the price fair?
What RIGL's price assumes
Rigel Pharmaceuticals, Inc. trades at 2.89× earnings against 18.6× for the median Biotechnology name, cheaper than its own group.
2.89
Trailing P/E · Biotechnology median 18.6 · cheaper than the typical name in its group
Details›
- Healthcare median P/E509 names
- 26.0
- Biotechnology median P/E244 names
- 18.6
- Market capitalisation
- $902M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.